Clearance Summary
Pentacam AXL received FDA 510(k) clearance under submission number K152311, sponsored by Oculus Optikgerate GmbH. The device was reviewed via the Traditional premarket notification pathway and assigned to the Ophthalmic review panel. The statutory decision date of record is 2016-01-20.
- Submission: K152311
- Applicant / Sponsor: Oculus Optikgerate GmbH
- Clearance pathway: Traditional
- Review panel: Ophthalmic
- Device class: Class II
- Regulation citation: 21 CFR 886.1850
- Decision date: 2016-01-20
Classification & Regulation
This clearance is catalogued under FDA product code MXK and 21 CFR 886.1850, within the Ophthalmic review panel as a Class II device.